Evaluating anticancer agents on 3D bioprinted organoid tumors (BOT) to reduce cost and accelerate therapeutic discovery.
Year: 2022
Type: conference-abstract
Source: Journal of Clinical Oncology
Institution: University of Alabama at Birmingham
Language: English
Subfield: Biomedical Engineering
Field: Engineering
Domain: Physical Sciences
Open Access status: closed
Funder: National Institutes of Health
OpenAlex ID: W4281671283
